{"database": "openregs", "table": "oira_reviews", "rows": [[32, "0910-ZC92", "0910", "Bioequivalence Studies With Pharmacokinetic Endpoints for Drugs Submitted Under an Abbreviated New Drug Application; Guidance for Industry; Availability", "Notice", "No", "2026-04-28", null, null, null, null]], "columns": ["rowid", "rin", "agency_code", "title", "stage", "economically_significant", "date_received", "date_completed", "decision", "date_published", "major"], "primary_keys": ["rowid"], "primary_key_values": ["32"], "units": {}, "query_ms": 0.44839398469775915, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}